Hexyl isocyanate → HCID 10226761, 화합물

HRID 1828594

반응식

HRID 1828594 반응식
[CH2:1]([N:7]=[C:8]=[O:9])[CH2:2][CH2:3][CH2:4][CH2:5][CH3:6].[Cl:10][C:11]1[CH:16]=[CH:15][C:14]([C:17]2[N:18]=[CH:19][N:20]([CH3:30])[C:21]=2[C:22]2[CH:27]=[CH:26][C:25]([Cl:28])=[CH:24][C:23]=2[Cl:29])=[CH:13][CH:12]=1>>[CH2:1]([NH:7][C:8]([C:19]1[N:20]([CH3:30])[C:21]([C:22]2[CH:27]=[CH:26][C:25]([Cl:28])=[CH:24][C:23]=2[Cl:29])=[C:17]([C:14]2[CH:15]=[CH:16][C:11]([Cl:10])=[CH:12][CH:13]=2)[N:18]=1)=[O:9])[CH2:2][CH2:3][CH2:4][CH2:5][CH3:6]

참가 물질

3

실험 절차

Using essentially the same procedure as Example 33, but using n-hexyl isocyanate (0.040 mL, 0.30 mmol), 4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-1-methylimidazole (50 mg, 0.15 mmol) from Example 32, Step C was converted to the title compound after purification twice by Prep TLC (25% ethyl acetate in hexanes).

출처 및 근거

ORD 기록
ord-b77ffdec14bc4361b8a15c5b218fb940
출처 데이터셋
uspto-grants-2006_06
특허 번호
US07057051B2

연결된 노트

불러오는 중…